SCHEMBL19628265

SCHEMBL19628265

CC(C)N(CC/N=C/c1cc2ccccc2c(-c2c(O)c(/C=N/CCN(Cc3cc(C(C)(C)C)cc(C(C)(C)C)c3O)C(C)C)cc3ccccc23)c1O)Cc1cc(C(C)(C)C)cc(C(C)(C)C)c1O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 6/20 0.42
ALOX5 P09917 4/20 0.35
PTGS2 P35354 4/20 0.35
CYP1A2 P05177 3/20 0.33
CYP2C19 P33261 3/20 0.33
CYP2C9 P11712 2/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
CYP2D6 P10635 2/20 0.32
GAA P10253 2/20 0.31
MGAM O43451 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
SYK P43405 1/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19628264 0.88 HIF1A (0.52) HIF1AALOX5PTGS2CYP1A2CYP2C19
SCHEMBL19628267 0.85 HIF1A (0.51) HIF1AALOX5PTGS2CYP1A2CYP2C19
SCHEMBL25039850 0.73 HIF1A (0.49) HIF1AALOX5PTGS2CYP1A2CYP2C19
SCHEMBL16153735 0.72 CYP2C19 (0.53) HIF1ACYP1A2CYP2C19CYP2C9CYP3A4
SCHEMBL20810448 0.71 CYP2D6 (0.43) HIF1AALOX5PTGS2CYP1A2CYP2C19
SCHEMBL20810369 0.69 CYP2C19 (0.41) HIF1ACYP1A2CYP2C19CYP2C9TSHR
SCHEMBL8352502 0.69 HIF1A (0.53) HIF1AALOX5PTGS2CYP1A2CYP2C19
SCHEMBL14804453 0.68 ALOX5 (0.43) HIF1AALOX5PTGS2CYP1A2CYP2C19
SCHEMBL14883383 0.67 ALOX5 (0.45) HIF1AALOX5PTGS2CYP1A2CYP2C19
SCHEMBL17656826 0.67 ALOX5 (0.45) HIF1AALOX5PTGS2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170335061-A1 ISOTACTIC POLYETHERS AND BIMETALLIC CATALYSTS, METHODS OF MAKING SAME, AND USES THEREOF NAVY, SECRETARY OF THE UNITED STATES OF AMERICA 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170335061-A1 ISOTACTIC POLYETHERS AND BIMETALLIC CATALYSTS, METHODS OF MAKING SAME, AND USES THEREOF SQLE, PAOX, AGL HIF1A 4222/4885ALOX5 10/4885PTGS2 931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.